WuXi Biologics (Cayman) Inc Sustainability Reports
A global contract research, development, and manufacturing organization (CRDMO) providing end-to-end solutions for biologics discovery, development, and manufacturing.
Sector: Professional & technical services
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 5493001TD2TH6VDTJU11
FIGI: BBG00GTY47J8
16 reports from 2017 to 2025
